BioFire®

Respiratory Panel 2.1

www.BioFireDx.com

Run Summary
Sample ID: Everett Mccarthy 01/02/2005 Run Status: Completed Controls: Passed

Operator: Alysa Taylor (at) Run Date: 24 Jun 2022 12:53 PM Instrument: 2FA08059

Negative
Report the Results
Results Summary
Detected Not Detected
Adenovirus
Coronavirus 229E
Coronavirus HKU1
Coronavirus NL63
Coronavirus OC43
Coronavirus SARS-CoV-2
Human Metapneumovirus
Human Rhinovirus/Enterovirus
Influenza A
Influenza B
Parainfluenza Virus
Respiratory Syncytial Virus
Bordetella parapertussis
Bordetella pertussis
Chlamydia pneumoniae
Mycoplasma pneumoniae

Pouch Summary
Pouch RP2.1 v1.0 Serial # 53692844 Lot # 28JZ21
Laboratory Facility: RapiCare

Address: 620 East Welsh Road

Horsham, PA 19044

CLIA Number: 39D2208283

Test Type: RT-PCR
Sampling Method: Nasopharyngeal Swab

Date of visit: June 24, 2022

Time of collection: 12:53 PM

Name: Everett Mccarthy

Date of Birth: 01/02/2005
Test Result: Negative Covid-19 RT-PCR

The BioFire RP2.1-EZ is a real-time, nested multiplexed polymerase chain reaction test (PCR) designed to
simultaneously identify nucleic acids from 16 different viruses, including SARS-CoV-2, and 4 bacteria associated
with respiratory tract infection, from a single nasopharyngeal swab (NPS) specimen in transport media.
The SARS-CoV-2 primers contained in the BioFire RP2.1-EZ are designed to detect RNA from the SARS-CoV-2 virus
in nasopharyngeal swabs from patients who are suspected of COVID-19 by their healthcare provider.